Planned share buyback to service the new employee share programs

Erlangen, Germany |  Nov 22, 2018

  • Share buyback with a maximum volume of EUR 45 million to service new employee share programs
  • Buyback to be executed between November 26, 2018, and January 25, 2019, at the latest

Since November 12, 2018, Siemens Healthineers employees in many countries have had the option of participating in their company's own regular share program for the first time. In this context, eligible employees can purchase shares of Siemens Healthineers AG and, after a multi-year holding period, receive an additional "matching" share in their share account for every three shares held, providing that the respective plan conditions have been met. In addition, employees in Germany can participate in a Basic Share Program subsidized by Siemens Healthineers, which also entitles them to receive matching shares. "The new share programs mark a significant contribution to establishing a sustainable ownership culture at Siemens Healthineers," said Jochen Schmitz, Chief Financial Officer of Siemens Healthineers AG.

The new share programs are similar to the successful Share Matching Program and Basic Share Program of Siemens AG and will replace them for the employees of Siemens Healthineers in the future. To service the employee share programs, Siemens Healthineers will execute a share buyback program with a maximum volume of EUR 45 million between November 26, 2018, and January 25, 2019, at the latest.


Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.
In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide. Further information is available at www.siemens-healthineers.com.

This document does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in the United States of America, Australia, Canada, Japan or in any jurisdiction to whom or in which such offer o solicitation is unlawful. This press release is neither an advertisement nor a securities prospectus and should not be relied upon in making any investment decision to purchase, subscribe for or otherwise acquire any shares. This press release is not directed to or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. This press release and the information contained herein are for information purposes only and do not constitute a prospectus or an offer to sell or a solicitation of an offer to buy shares.

This document contains statements related to our future business and financial performance and future events or developments involving Siemens Healthineers that may constitute forward-looking statements. These statements may be identified by words such as “expect”, “forecast”, “anticipate”, “intend”, “plan”, “believe”, “seek”, “estimate”, “will”, “target” or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to shareholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of Siemens Healthineers’ management, of which many are be-yond Siemens Healthineers’ control. As they relate to future events or developments, these statements are subject to a number of risks, uncertainties and factors, including, but not limited to those described in the respective disclosures. Should one or more of these risks, uncertainties or factors materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Siemens Healthineers may (negatively or positively) vary materially from those described explicitly or implicitly in the relevant forward-looking statement. All forward-looking statements only speak as of the date when they were made and Siemens Healthineers neither intends, nor assumes any obligation, unless required by law, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This document includes – in the applicable financial reporting framework not clearly defined – supplemental financial measures that are or may be alternative performance measures (non-GAAP-measures). These supplemental financial measures may have limitations as analytical tools and should not be viewed in isolation or as alternatives to measures of Siemens Healthineers’ net assets and financial positions or results of operations as presented in accordance with the applicable financial reporting frame-work in its Consolidated Financial Statements. Other companies that report or describe similarly titled alternative performance measures may calculate them differently, which may therefore not be comparable.

Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.


Contact

Philipp Grontzki
Siemens Healthcare GmbH
Henkestr. 127
91052 Erlangen
Germany
+49 152 03350194
philipp.grontzki@siemens-healthineers.com

Reference Number: PR-20181122046SHS